Singapore markets close in 1 hour 12 minutes
Straits Times Index
3,108.98 -11.26 (-0.36%) Nikkei
26,423.47 +269.66 (+1.03%) Hang Seng
21,876.63 +46.28 (+0.21%) FTSE 100
7,220.17 -12.48 (-0.17%) BTC-USD
20,215.61 +1,098.98 (+5.75%) CMC Crypto 200
439.81 +19.67 (+4.68%)
Samsung Biologics Co.,Ltd. (207940.KS)
KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
At close: 03:30PM KST
| Previous close | 791,000.00 |
| Open | 793,000.00 |
| Bid | 800,000.00 x 0 |
| Ask | 806,000.00 x 0 |
| Day's range | 790,000.00 - 805,000.00 |
| 52-week range | 693,000.00 - 1,047,000.00 |
| Volume | |
| Avg. volume | 54,140 |
| Market cap | 57.295T |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Jul 2022 - 29 Jul 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1,084,840.00 |
- Motley Fool
What to Expect From Biogen's $2.3 Billion Shopping Spree
After selling its stake in a biosimilar joint venture with Samsung Biologics, Biogen (NASDAQ: BIIB) has reportedly now brought Goldman Sachs on board to identify potential acquisition targets. Brian Orelli: Biogen sold off its stake in its biosimilar joint venture that it has with Samsung Biologics.
- Zacks
Biogen (BIIB) to Sell Biosimilar JV Stake to Samsung Biologics
Biogen (BIIB) is selling its equity stake in the Samsung Bioepis joint venture to partner Samsung Biologics
© 2022 Yahoo. All rights reserved.
